Evogene and Tel Aviv University Launch Drug Discovery Initiative

Evogene and Tel Aviv University's Blavatnik Center for Drug Discovery Announce Joint Initiative to Accelerate AI-Driven Small-Molecule Drug Discovery

Open the article to view the coverage from The AI Journal

Evogene and BCDD collaborate in drug discovery initiative - BioTuesdays

Evogene (NASDAQ: EVGN; TASE: EVGN) and Tel Aviv University’s Blavatnik Center for Drug Discovery (BCDD) have announced a collaboration that aims to expedite the development of small-molecule drug discovery originating from Israeli academic research. The agreement will combine computational and experimental tools for academic teams and scientific entrepreneurs seeking to advance early-stage drug candidates. The partnership will provide a framewor…

Evogene and Tel Aviv University launch drug discovery initiative

Evogene and Tel Aviv University’s BCDD have partnered to expedite small-molecule drug discovery originating from Israeli academic research.The post Evogene and Tel Aviv University launch drug discovery initiative appeared first on Hospital Management.